TABLE 2.
BODY COMPOSITION AND RISK FACTOR RESPONSES BY GROUPa
| High Caloric Expenditure | Standard Cardiac Rehabilitation | Combined Groups | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 5-Months | P value Within Group | Baseline | 5-Months | P value within group | P value Between Group | Baseline | 5-Months | P- value Within Group | |
| Body weight, kg | 94 ±16 | 85 ±15 | <.001 | 95 ± 14 | 92±14 | <.001 | <.001 | 95 ± 15 | 89 ± 15 | <.001 |
| Body mass index, kg/m2 | 32 ± 4 | 29 ± 4 | <.001 | 32 ± 5 | 31 ± 5 | <.001 | <.001 | 32 ± 4 | 30 ± 4 | <.001 |
| Fat mass, kg | 33 ± 8 | 28 ± 8 | <.001 | 34 ± 4 | 31 ± 8 | .003 | <.001 | 34 ± 8 | 29 ± 8 | <.001 |
| Waist circumference, cm | 110 ± 10 | 103 ± 10 | <.001 | 111 ± 11 | 106 ± 10 | <.001 | .018 | 110 ± 10 | 105 ± 10 | <.001 |
| Systolic blood pressure, mm Hg | 133 ± 18 | 125 ± 23 | <.007 | 134 ± 19 | 124 ± 19 | .0003 | .73 | 133 ± 18 | 125 ± 21 | .0001 |
| Diastolic blood pressure, mm Hg | 74 ± 11 | 67 ± 8 | <.001 | 75 ± 8 | 71 ± 10 | .051 | .12 | 74 ± 9 | 69 ± 9 | .0001 |
| Total cholesterol, mg/dL | 162 ± 36 ‡ | 155 ± 33 | .059 | 148 ± 27 | 149 ± 30 | .72 | .11 | 155 ± 33 | 153 ± 32 | .299 |
| Triglycerides, mg/dL | 149 ± 80 ‡ | 118 ± 67 | .001 | 114 ± 28 | 116 ± 76 | .11 | .07 | 132 ± 80 | 114 ± 62 | .007 |
| High density lipoprotein(HDL) cholesterol, mg/dL | 39 ± 9 | 42 ± 9 | .001 | 42 ± 12 | 44 ± 12 | .11 | .24 | 41 ± 10 | 44 ± 11 | .001 |
| Low density lipoprotein(HDL) cholesterol, mg/dL | 94 ± 27 | 89 ± 24 | .08 | 84 ± 20 | 84 ± 21 | .86 | .26 | 89 ± 24 | 87 ± 23 | .183 |
| Total cholesterol/HDL ratio | 4.3 ± 1.2 † | 3.8 ± 1.0 | <.001 | 3.6 ± 0.9 | 3.5 ± 1.0 | .34 | .01 | 4.0 ±1.1 | 3.6 ± 1.0 | .001 |
| High sensitivity C-reactive protein, ng ml−1 | 3.3 ± 4.1 | 3.1 ± 4.7 | .14 | 3.2 ± 3.0 | 2.8 ± 2.3 | .11 | .43 | 3.2 ± 3.6 | 2.7 ± 3.1 | .04 |
| Insulin, μIU ml−1 | 19 ± 7 | 13 ± 5 | <.001 | 19 ± 8 | 16 ± 6 | <.001 | .17 | 19 ± 7 | 14 ± 6 | .001 |
| Glucose disposal, mg·FFM−1·minute−1 | 6.9 ±3.1 | 8.7 ± 3.5 | .0001 | 7.2 ± 2.3 | 8.2 ± 2.4 | .001 | .008 | 7.1 ± 2.7 | 8.5 ± 3.2 | .0001 |
| Plasminogen activator inhibitor, ng ml−1 | 24 ± 11 | 19 ± 21 | .05 | 20 ± 8 | 19 ± 11 | .49 | .37 | 22 ± 9 | 19 ± 16 | .06 |
| Peak oxygen uptake, mLO2·kg−1·minute−1 | 22 ± 6 | 24 ± 8 | .004 | 22 ± 5 | 24 ± 6 | .01 | .85 | 22 ± 5 | 24 ± 7 | .0002 |
a
Adapted from reference 17
Results presented as mean ± SD
‡
P= .05,
†
P<.005. Baseline comparison between groups, otherwise P=NS
For conversion to international units (mmol/L):
1) Multiply total cholesterol, LDL-cholesterol, and HDL-cholesterol by 0.02586
2) Multiply triglycerides by 0.01129
3) Multiply glucose by 0.05555